NanoVibronix, Inc.

For the period ended Nov 19, 2025. Filed Nov 19, 2025.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 19, 2025 · Filed Nov 19, 2025

Use the contents to explore the available documents and sections.

FEED$1.03-69.3%Stored close · as of Sep 15, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.1 · Looking Ahead

Looking Ahead

We are energized by the momentum behind ENvue and confident in our ability to execute. In the coming weeks, we will introduce our Board of Directors following our Annual Meeting on December 4, 2025, announce key additions to our leadership team and share early clinical progress that further validates the impact of ENvue.

Thank you for your continued support as we advance this important transformation.

Warm regards,

Doron Besser, M.D.

Chief Executive Officer

NanoVibronix, Inc.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.